Panel Discussion
Monday, October 06
05:55 PM - 06:40 PM
Live in Berlin
Less Details
The emergence of Generative AI and Large Language Models (LLMs) is transforming how competitive intelligence is gathered, analyzed, and applied across industries. In pharmaceuticals—where regulation, data sensitivity, and scientific complexity are paramount—these technologies offer unprecedented opportunities and novel risks. This panel will explore how CI professionals can harness AI to gain actionable insights, maintain compliance, and stay ahead of market trends. Panelists will also discuss the strategic and operational implications of integrating these tools into CI workflows.
Petra Leiding is Director of Market Intelligence & Strategic Projects at HELM AG, where she has worked for over seven years. She specializes in uncovering market insights to drive new business opportunities at HELM Pharma. Petra promotes 2 and 3D printing opportunities including project lead of technical development, market access and financials. Previously, Petra held team leader roles in business insights and analytics at Teva Pharmaceuticals and AstraZeneca, bringing overall more than 25 years of professional experience in market research, pricing, and strategies mostly within the pharmaceutical industry.
The Pop in Your Job
I love transforming complex data into intelligent, automated solutions that truly make an impact. Seeing how AI and automation streamline workflows, empower teams and at the same time gives freedom for strategic projects as well as in depths analyses motivates me every day!
Mirko Lotz is the Global Market Intelligence Manager at Bachem, where he has been contributing since 2016 in various Science Marketing roles before transitioning into his current global Market and Competitive Intelligence (MI/CI) position. Prior to joining Bachem, he spent nearly eight years as a Business Development Engineer and Consultant. Mirko holds a PhD in Biochemistry from the University of Frankfurt.